ETN
53
-2
DE
43
-3
AME
66
4
AA
76
3
APD
47
-3
CF
44
-4
AZO
45
5
BSX
60
3
CLX
51
-2
AMT
25
-5
VIX
32
-12
AVGO
42
18
DLTR
62
-4
ADI
72
2
COF
67
2
ESS
45
-2
ALLE
41
-5
CCI
34
-2
CCL
65
3
AAP
1
-4
ETN
53
-2
DE
43
-3
AME
66
4
AA
76
3
APD
47
-3
CF
44
-4
AZO
45
5
BSX
60
3
CLX
51
-2
AMT
25
-5
VIX
32
-12
AVGO
42
18
DLTR
62
-4
ADI
72
2
COF
67
2
ESS
45
-2
ALLE
41
-5
CCI
34
-2
CCL
65
3
AAP
1
-4
Financhill
Back

STF Tactical Growth & Income ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
27

TUGN
STF Tactical Growth & Income ETF

Last Price:
$25.40
Seasonality Move:
-2.07%
Buy
78

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.21
Seasonality Move:
11.35%
Sell
27
STF Tactical Growth & Income ETF (TUGN) is a Sell

Is STF Tactical Growth & Income ETF a Buy, Sell or Hold?

  • The current STF Tactical Growth & Income ETF [TUGN] share price is $25.29. The Score for TUGN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • TUGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.35. The Score for CDTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TUGN Stock Price Chart

What is STF Tactical Growth & Income ETF's stock price today?

  • The STF Tactical Growth & Income ETF share price today is $25.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TUGN is experiencing slight selling pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.35
    The current trend is moderately bullish and CDTX is experiencing slight buying pressure.

TUGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.56 Buy
Relative Strength Index (14 RSI): 41.52 Sell
Chaikin Money Flow: -2669 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.3 - 25.9) Sell
Bollinger Bands (100): (25.12 - 26.24) Sell

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.79 Buy
Relative Strength Index (14 RSI): 84.87 Buy
Chaikin Money Flow: 261741 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (192.91 - 237.53) Buy
Bollinger Bands (100): (54.69 - 176.45) Buy

TUGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.59 Sell
20-day SMA: 25.6 Sell
50-day SMA: 25.92 Sell
200-day SMA: 24.29 Buy
8-day EMA: 9.96 Buy
20-day EMA: 4.57 Buy
50-day EMA: 1.94 Buy
200-day EMA: 0.5 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.19 Buy
20-day SMA: 220.08 Buy
50-day SMA: 159.67 Buy
200-day SMA: 72.77 Buy
8-day EMA: 219.95 Buy
20-day EMA: 209.45 Buy
50-day EMA: 171.39 Buy
200-day EMA: 93.26 Buy

STF Tactical Growth & Income ETF Earnings Growth & TUGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

STF Tactical Growth & Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):